Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Enfusion, Inc. Class A Common Stock (NY: ENFN )

11.00 -0.15 (-1.35%)
Official Closing Price Updated: 7:00 PM EST, Feb 14, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Enfusion, Inc. Class A Common Stock

< Previous 1 2 3 Next >
Monday.com Sees RS Rating Rise To 92 On Q4 Earnings Beat
monday.com sees its Relative Strength Rating enter the elite 90-plus level. 
Via Investor's Business Daily
Fastly Stock Earns 85 Relative Strength Rating
One key metric to look for in a stock is an 80-plus Relative Strength Rating. Fastly stock cleared that benchmark Monday, with a jump to 85. 
Via Investor's Business Daily
Nutanix Stock Earns RS Rating Upgrade
The Relative Strength (RS) Rating for Nutanix stock entered a new percentile Wednesday, with a rise from 66 to 81. 
Via Investor's Business Daily
DigitalOcean Stock Gets RS Rating Upgrade
DigitalOcean stock had its Relative Strength Rating upgraded to 75 Monday — a nice improvement, but still shy of the preferred 80-plus score. 
Via Investor's Business Daily
Freshworks Stock Gets IBD Rating Upgrade To 96
Computer software Freshworks stock saw its IBD SmartSelect Composite Rating jump to 96 Friday, up from 93 the day before. 
Via Investor's Business Daily
Top-Rated Stocks: DigitalOcean Sees Composite Rating Climb To 96
The revised score means DigitalOcean stock currently tops 96% of all other stocks in terms of key performance metrics and technical strength. 
Via Investor's Business Daily
A Glimpse Into The Expert Outlook On Enfusion Through 4 Analysts
Via Benzinga
Earnings Outlook For Enfusion
Via Benzinga
JP Morgan Downgrades Enfusion: Here's What You Need To Know
Via Benzinga
12 Information Technology Stocks Moving In Friday's Pre-Market Session
Via Benzinga
This Analyst With 85% Accuracy Rate Sees Around 10% Upside In Alphabet - Here Are 5 Stock Picks For 2024 From Wall Street's Most Accurate Analysts
Via Benzinga
This Analyst With 82% Accuracy Rate Sees Around 28% Upside In Apple - Here Are 5 Stock Picks For Last Week From Wall Street's Most Accurate Analysts
Via Benzinga
12 Information Technology Stocks Moving In Thursday's Pre-Market Session
Via Benzinga
Earnings Preview: Enfusion
Via Benzinga
Why Enfusion (ENFN) Stock Is Exploding Higher
Enfusion Inc (NYSE: ENFN) shares are trading higher by 20% to $11.06 Monday afternoon following a report suggesting the company is attracting takeover interest. What Else? 
Via Benzinga
Fastly Stock Gets IBD Rating Upgrade
One key metric to look for in a stock is an 80-plus Relative Strength Rating. Fastly stock cleared that benchmark Tuesday, with a jump to 84. 
Via Investor's Business Daily
ENFN Stock Earnings: Enfusion Misses EPS, Misses Revenue for Q2 2024
ENFN stock results show that Enfusion missed analyst estimates for earnings per share and missed on revenue for the second quarter of 2024. 
Via InvestorPlace
ENFN Stock Earnings: Enfusion Beats EPS, Beats Revenue for Q1 2024
ENFN stock results show that Enfusion beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024. 
Via InvestorPlace
The 3 Most Undervalued Under-$10 Stocks to Buy in April 2024
Equities have only become more expensive, but investors should still lookout for the most undervalued under-$10 stocks to buy in April. 
Via InvestorPlace
Wall Street Favorites: 3 Under-$10 Stocks with Strong Buy Ratings for March 2024
U.S. equities market is rallying, but there are still interesting investments to make, especially for these strong-buy stocks under $10. 
Via InvestorPlace
12 Information Technology Stocks Moving In Thursday's Pre-Market Session
Via Benzinga
Earnings Scheduled For March 12, 2024
Companies Reporting Before The Bell • Aurora Mobile (NASDAQ:JG) is likely to report earnings for its fourth quarter. 
Via Benzinga
Wall Street's Top 10 Stock Calls This Week - Saturday, March 2
What has Wall Street been buzzing about this week? Here are the top 5 buy calls and the top 5 sell calls made by Wall Street's best analysts during the week of Feb. 26 through March 1. 
Via Talk Markets
Enfusion Stock To Remain Range-Bound In 2024 Amid Stable Hedge Fund Market: Goldman Sachs Analyst Downgrades Stock
Goldman Sachs downgrades Enfusion from Neutral to Sell, lowers price target from $9 to $8, expects stock to be range-bound in 2024 with slower growth than Street estimates due to company-specific... 
Via Benzinga
This Analyst With 84% Accuracy Rate Sees Around 13% Upside In Darden Restaurants - Here Are 5 Stock Picks For 2023 From Wall Street's Most Accurate Analysts
U.S. stocks closed slightly lower on Friday, but the S&P 500 closed out last year with a gain of 24.2%. The Dow closed the year with a 13.7% gain, while the Nasdaq Composite surged 43.4% to record its... 
Via Benzinga
Topics Stocks
Exposures US Equities
Hidden Gems: 3 Small-Cap Tech Stocks With Huge Potential
These top small-cap tech stocks are the ones to buy in for long-term returns as profits are evident from innovations. 
Via InvestorPlace
The 3 Most Undervalued Under-$10 Stocks to Buy in September 2023
Undervalued stocks are not just found in older industries; rather, many can be found in emerging spaces as well. 
Via InvestorPlace
12 Information Technology Stocks Moving In Monday's Intraday Session
Via Benzinga
McKesson, ICU Medical, Novavax And Other Big Stocks Moving Higher On Tuesday
U.S. stocks traded lower, with the Dow Jones dropping around 50 points on Tuesday. Here are some big stocks recording gains in today’s session. 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For April 3, 2023
Via Benzinga
< Previous 1 2 3 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.